Evaluation of Circulating MicroRNA Profiles in Brazilian Women with Polycystic Ovary Syndrome: A Preliminary Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Oct 7

PMID 36206272

Authors

Giovana De Nardo Maffazioli

Edmund Chada Baracat

Jose Maria Soares

Katia Candido Carvalho

Gustavo Arantes Rosa Maciel

Affiliations

Soon will be listed here.

Abstract

Objective: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrinopathy, which etiology encompasses complex genetic traits associated with epigenetic factors, including differences in microRNA (miRNA) expression in a variety of tissues. The circulating form of these molecules is raising attention in the syndrome not only as potential biomarkers of PCOS but also as possible therapeutic targets. The aim of this study was to explore the circulating miRNA profiles present in a cohort of Brazilian women with and without PCOS and to evaluate the potential role of miRNAs in the pathophysiology of the syndrome.

Methods: Cross-sectional study of 36 well-characterized PCOS women and 16 healthy controls. Clinical, hormone and metabolic data were recorded and evaluated. The expression profile of the 201 circulating miRNA selected were analyzed by taqman quantitative real time polymerase chain reactions (RT-PCR) using a customized Open Array platform. Statistical and bioinformatic analyzed were performed.

Results: Circulating miR-21-5p, miR-23a-3p and miR-26a-5p were upregulated, and miR-103a-3p, miR-376a-3p, miR-19b-3p and miR-222-3p were downregulated in women with PCOS compared to healthy normo-ovulatory controls. miR-21-5p, miR-103a-3p and miR-376a-3p levels correlated positively with androgen levels. These miRNAs, in combination, were related to pathways involved in insulin signaling, steroids biosynthesis and endothelial regulation as well as in folliculogenesis.

Conclusion: In this study, we identified a specific circulating miRNA signature in Brazilian women with PCOS. According to our data, circulating miR-21-5p, miR-23a-3p, miR-26a-5p, miR-103a-3p, miR-376a-3p, miR-19b-3p and miR-222-3p may represent potential candidates for differential diagnosis of PCOS in the future.

Citing Articles

Correction: Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary study.

Maffazioli G, Baracat E, Soares Jr J, Carvalho K, Maciel G PLoS One. 2025; 20(1):e0317139.

PMID: 39752342 PMC: 11698354. DOI: 10.1371/journal.pone.0317139.

MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility.

Chico-Sordo L, Garcia-Velasco J Int J Mol Sci. 2024; 25(23.

PMID: 39684688 PMC: 11640832. DOI: 10.3390/ijms252312979.

Building a Human Ovarian Antioxidant ceRNA Network "OvAnOx": A Bioinformatic Perspective for Research on Redox-Related Ovarian Functions and Dysfunctions.

Tatone C, Emidio G, Battaglia R, Di Pietro C Antioxidants (Basel). 2024; 13(9).

PMID: 39334761 PMC: 11428640. DOI: 10.3390/antiox13091101.

Exosome Therapy and Photobiomodulation Therapy Regulate mi-RNA 21, 155 Expressions, Nucleus Acetylation and Glutathione in a Polycystic Ovary Oocyte: An In Vitro Study.

Sahraeian S, Abbaszadeh H, Taheripanah R, Edalatmanesh M, Keshavarzi S, Ghazifard A J Lasers Med Sci. 2024; 15:e10.

PMID: 39051004 PMC: 11267104. DOI: 10.34172/jlms.2024.10.

MicroRNA-21 modulates brown adipose tissue adipogenesis and thermogenesis in a mouse model of polycystic ovary syndrome.

Rezq S, Huffman A, Basnet J, Alsemeh A, do Carmo J, Yanes Cardozo L Biol Sex Differ. 2024; 15(1):53.

PMID: 38987854 PMC: 11238487. DOI: 10.1186/s13293-024-00630-2.

References

Jiang L, Huang J, Li L, Chen Y, Chen X, Zhao X . MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. J Clin Endocrinol Metab. 2015; 100(5):E729-38. PMC: 4422895. DOI: 10.1210/jc.2014-3827. View

Sorensen A, Wissing M, Englund A, Dalgaard L . MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes. J Clin Endocrinol Metab. 2016; 101(4):1579-89. PMC: 4880172. DOI: 10.1210/jc.2015-3588. View

Yu Y, Li G, He X, Lin Y, Chen Z, Lin X . MicroRNA-21 regulate the cell apoptosis and cell proliferation of polycystic ovary syndrome (PCOS) granulosa cells through target toll like receptor TLR8. Bioengineered. 2021; 12(1):5789-5796. PMC: 8806582. DOI: 10.1080/21655979.2021.1969193. View

Naji M, Aleyasin A, Nekoonam S, Arefian E, Mahdian R, Amidi F . Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes. Sci Rep. 2017; 7(1):14671. PMC: 5676684. DOI: 10.1038/s41598-017-13250-1. View

Xiong W, Lin Y, Xu L, Tamadon A, Zou S, Tian F . Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population. J Ovarian Res. 2017; 10(1):10. PMC: 5307830. DOI: 10.1186/s13048-016-0298-8. View

Ilie I, Georgescu C . Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA. Adv Clin Chem. 2015; 71:25-45. DOI: 10.1016/bs.acc.2015.06.001. View

Li Q, Pangas S, Jorgez C, Graff J, Weinstein M, Matzuk M . Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol. 2008; 28(23):7001-11. PMC: 2593383. DOI: 10.1128/MCB.00732-08. View

Mori M, Ludwig R, Garcia-Martin R, Brandao B, Kahn C . Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease. Cell Metab. 2019; 30(4):656-673. PMC: 6774861. DOI: 10.1016/j.cmet.2019.07.011. View

Deswal R, Dang A . Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2020; 113(3):661-669.e2. DOI: 10.1016/j.fertnstert.2019.11.001. View

10.

Jiang Q, Han Y, Gao H, Tian R, Li P, Wang C . Ursolic acid induced anti-proliferation effects in rat primary vascular smooth muscle cells is associated with inhibition of microRNA-21 and subsequent PTEN/PI3K. Eur J Pharmacol. 2016; 781:69-75. DOI: 10.1016/j.ejphar.2016.04.001. View

11.

Carletti M, Christenson L . MicroRNA in the ovary and female reproductive tract. J Anim Sci. 2008; 87(14 Suppl):E29-38. PMC: 3118666. DOI: 10.2527/jas.2008-1331. View

12.

Butler A, Ramachandran V, Sathyapalan T, David R, Gooderham N, Benurwar M . microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index. Front Endocrinol (Lausanne). 2020; 11:206. PMC: 7199502. DOI: 10.3389/fendo.2020.00206. View

13.

Wu H, Heneidi S, Chuang T, Diamond M, Layman L, Azziz R . The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2014; 99(12):E2754-61. PMC: 4255124. DOI: 10.1210/jc.2013-4435. View

14.

Roth L, McCallie B, Alvero R, Schoolcraft W, Minjarez D, Katz-Jaffe M . Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome. J Assist Reprod Genet. 2014; 31(3):355-62. PMC: 3947080. DOI: 10.1007/s10815-013-0161-4. View

15.

Xu N, Azziz R, Goodarzi M . Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertil Steril. 2009; 94(2):781-3.e1. PMC: 2889203. DOI: 10.1016/j.fertnstert.2009.10.020. View

16.

Sathyapalan T, David R, Gooderham N, Atkin S . Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis. Sci Rep. 2015; 5:16890. PMC: 4652283. DOI: 10.1038/srep16890. View

17.

Hossain M, Sohel M, Schellander K, Tesfaye D . Characterization and importance of microRNAs in mammalian gonadal functions. Cell Tissue Res. 2012; 349(3):679-90. DOI: 10.1007/s00441-012-1469-6. View

18.

Mase Y, Ishibashi O, Ishikawa T, Takizawa T, Kiguchi K, Ohba T . MiR-21 is enriched in the RNA-induced silencing complex and targets COL4A1 in human granulosa cell lines. Reprod Sci. 2012; 19(10):1030-40. DOI: 10.1177/1933719112442245. View

19.

Azziz R, Sanchez L, Knochenhauer E, Moran C, Lazenby J, Stephens K . Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004; 89(2):453-62. DOI: 10.1210/jc.2003-031122. View

20.

Stubbs S, Stark J, Dilworth S, Franks S, Hardy K . Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab. 2007; 92(11):4418-26. DOI: 10.1210/jc.2007-0729. View